❖︎︎ A lot has happened without anything actually happening somehow. 

Global Blood Culture Test Market is projected to reach USD 6.6 billion by 2025 owing to prevalence of blood infections and infectious diseases. Blood culture is a laboratory test wherein the patient’s blood is injected in bottles that contain culture media to determine the existence of infection-producing microorganisms like fungi or bacteria in the patient’s blood. It aims at confirming the existence of microorganisms in the blood, identifying the microbial etiology of the blood infection, helping to determine the infection source like endocarditis, and providing an organism for suspicion of testing and optimization of antimicrobial therapy. This test examines a sample of patient’s blood for yeast or bacteria that might be the root cause of infection. However, the growing demand for enhanced diagnostic techniques for the diagnosis of infectious diseases is expected to boost the blood culture tests market with a CAGR of 8.6%.

Get Exclusive Free Sample Copy Of This Report @ https://bit.ly/3FNCnnA

The blood infection, if left undetected, may lead to a severe and fatal condition called sepsis. The symptoms of bacteremia or initial bacterial infection are moderate or high fever, breathlessness, chills, muscular pain, palpitations, headache, tachycardia, and nausea. With the growth of infection, the indications also get serious; which may include dehydration, mottled skin, dizziness, confusion, drop in blood pressure, swelling, and organ failure.

Though blood samples are used for the detection of virus n blood, blood culture is essentially used to detect fungi or bacteria. Blood culture test is mostly done in combination with the other diagnostic tests like CBC (complete blood count) or the other chemical analysis. Different techniques like manual/conventional, automated and semi-automated methods could also be used to conduct blood culture test.

New product inventions, numerous regulatory approvals, rising sepsis conditions, growing number of infections in blood, increasing research & development of novel testing instruments and increasing number of adoptions for rapid diagnostic techniques are some factors that are bound to fuel blood culture test industry in the years to come. Additionally, the increasing elderly population and predominance of infectious disorders are the rest of key factors for the growth of the market.

However, costly automated instruments and shortage of skilled laboratory technicians are hampering the blood culture test market growth. Nevertheless, rising investments in Research & Development programs and increasing private and public healthcare expenditure are estimated to drive the market in the forecast period.

Blood culture test industry is categorized on the basis of method, product, application, end-user and geography. In terms of method, the market is divided into manual, conventional, and automated method. Based on product, the market is divided into instruments, consumables, and software & services.

Consumables could be further classified into culture media type, kits, accessories, and reagents. In terms of application, blood culture tests industry is divided into fungemia, bacteremia, and mycobacterial. On the basis of end-users, the market is divided into academic research laboratories, independent diagnostic laboratories, hospital laboratories, etc.

Read Complete Report With TOC https://bit.ly/3atNyTT

Geographically, blood culture test market is segmented as North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. Europe and North America are predicted to dominate the market due to high spending power over healthcare. Asia Pacific is also expected to hold larger share in near future owing to the growing demand for blood culture tests from emerging nations.

The prominent blood culture test industry players profiled here are Abbott Laboratories, Bruker Corporation, Bayer Healthcare, bioMérieux SA, Becton Dickinson, Siemens AG, Merck, Thermo Fisher Scientific Inc., Beckman Coulter Inc. (Danaher) and Roche Diagnostics.

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email:ryan@millioninsights.com

Industry Insights

The global RFID blood monitoring systems market size was estimated at USD 104 million in 2014. Rising demand for efficient management system regarding blood & related products and growing awareness pertaining to minimize transfusion errors in medical process are some of the key factors driving RFID blood monitoring systems market. Rapidly consolidating healthcare sector and increase in volume of blood & related products inventory is further boosting up the demand for this technology in healthcare industry.

Technological advancements in RFID systems will not only provide identification details but also provide location information on a real time basis, which will further boost demand among end-users for these devices. Increase in R&D activities for the development of new management solutions and rising concerns for patient safety is expected to propel the growth of RFID blood monitoring systems. Growing adoption of RFID technologies by the hospitals and blood banks particularly in blood freezers and refrigerators further surges demand for this technology.

Download Full Research Report on RFID Blood Monitoring Systems Market @ https://www.millioninsights.com/industry-reports/rfid-blood-monitoring-systems-market

Some of the other factors driving the growth of the market are favorable regulatory policies for the approval of RFID technologies and rising trend of privatization of healthcare infrastructure that led to the introduction of modern technologies in the healthcare settings. In 2013, FDA approved iTrace which is a RFID-based tracking system that can be used in blood banks systems.

Product Insights

Radio frequency identification held majority of the market share in terms of revenue, with over USD 60 million in 2014 pertaining to the factors such as growing concerns for patient safety, increasing adoption of smart medical devices, favorable government initiatives, and rising need for reduction in healthcare cost. In addition, various application of RFID in healthcare system further drive the demand over the forecast period.

Radiofrequency identification tags held the significant market share owing to the demand of technologically advanced products such as alternative tags and sensory tags designs that uses Smart Active Label Technology (SAL) which is less susceptible to metal and liquid. In addition, it maximizes the profitability of medical facilities that is expected to further boost up its demand.

End Use Insights

Blood Banks emerged as the largest segment and was valued at over USD 85 million in 2014. Increasing need for patient safety, minimization of transfusion errors & wastage of blood products are amongst the key factors owing to the growing usage of RFID technologies in the blood banks. In addition, increasing number of blood banks and rising inventory of blood and blood products further expected to drive the demand of RFID technologies in blood banks. RFID technology helps in creating an efficient supply chain of blood products, right from the collection point to its delivery to the hospitals or clinical settings.

Regional Insight

North America dominated the regional segment in 2014 followed by Europe owing to rising number of blood banks, sophisticated healthcare infrastructure, growing demand for operational efficiency and favorable government initiatives. Increasing number of funding for the research activities in RFID technologies attribute to its growth in the region. Asia pacific region is expected to be the fastest growing segment over the forecast period. The growth in the region is driven by the factors such as improved healthcare infrastructure and increased penetration of RFID blood monitoring system. Low cost of RFID components such as original equipment manufacturing (OEM) services provided by China offers huge potential of RFID technologies in Asia pacific market.

Competitive Insights

Few of the key participants of RFID blood monitoring systems market include, TAGSYS; Wave Mark, Inc.; LogTag Recorders Ltd.; Solstice Medical LLC; Innerspace; LogiTag Ltd.; Terson Solutions and Mobile Aspects; Inc.

Request a Free Sample Copy of RFID Blood Monitoring Systems Market Report @ https://www.millioninsights.com/industry-reports/rfid-blood-monitoring-systems-market/request-sample

Market Segment

Product Outlook (Revenue, USD Million, 2012 - 2022)
• Systems
• Tags

End Use Outlook (Revenue, USD Million, 2012 - 2022)
• Blood Banks
• Hospital Blood Centers

Regional Outlook (Revenue, USD Million, 2012 - 2022)
• North America
• Europe
• Asia Pacific
• RoW